RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

Fintel reports that on January 9, 2025, RBC Capital upgraded their outlook for Canadian Imperial Bank of Commerce (NYSE:CM) ...

In the last two years, it’s happened for the fifth time. The S&P 500 was up 26% in 2023 and 25% in 2024, for the best ...

RBC Capital initiated coverage of Amentum (AMTM) with a Sector Perform rating and $24 price target Amentum is a leading government services ...

RBC Capital analyst Gregory Renza maintained a Buy rating on Exelixis (EXEL – Research Report) on January 7 and set a price target of $38.00.

Blake Gwinn, the head of US Rates Strategy at RBC Capital Markets, joins Yahoo Finance's Morning Brief to explain why the ...

A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...

A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...